應用於Legumain 偵測之磁振造影對比劑 Gd-NBCB-TTDA-Legumain 之研究

Synthesis and Characterization of Gd-NBCB-TTDA-Legumain for Legumain Sensing

林英妊(Ying-Ren Lin)

指導教授 ： 王雲銘

國立交通大學/生物科技學院/生物科技學系暨研究所/碩士(2011年)

https://doi.org/10.6842/NCTU.2011.00660

摘要

磁振造影是目前臨床醫學上常使用的診斷工具，不同於其他造影技術，其對軟組織的成像具有相當的效果，但靈敏度卻稍顯不足。因此本研究設計合成一條由8個胺基酸所組成的胜肽，其對Legumain酵素具有目標性，且在多種腫瘤上都有過度表現。並在胜肽N端鍵結NBCB-TTDA，形成對腫瘤組織中的Legumain具有專一辨識功能的磁振造影對比劑Gd-NBCB-TTDA-Legumain。在20 MHz、37.0 ± 0.1 °C下，Gd-NBCB-TTDA-Legumain所求得弛緩率(r1)為4.94 mM-1s-1。在T1弛緩時間變化量的實驗中發現，當有存在3T3-Legumain cell lysate時，T1約上升20 %。在細胞毒性實驗中發現，在高濃度(1 mM) Gd-NBCB-TTDA-Legumain培養下，細胞存活率仍達85 %以上，推測若以低劑量打入動物體內不具有抑制細胞生長的危險性。在體內(in vivo)實驗研究中，Gd-NBCB-TTDA-Legumain可目標化至CT-26腫瘤且提高其訊號強度，而使腫瘤位置容易辨別。結果顯示此磁振造影對比劑有潛力對有Legumain表現之腫瘤進行診斷及追蹤。

關鍵字

磁振造影 ； 弛緩率

並列摘要

Magnetic resonance imaging (MRI) has become the leading tool for
imaging and ability to resolve different soft tissues. MRI has not been
effectively used for molecular imaging because of its low sensitivity. In
this study, we designed and synthesized a novel contrast agent (CA),
Gd-NBCB-TTDA-Legumain, to image the activity of asparaginyl
endopeptidase, known as Legumain, in a tumor, noninvasively using MR
imaging. The T1 relaxivity of Gd-NBCB-TTDA-Legumain was 4.94
mM-1 s-1 at 37± 0.1 °C and 0.47 T. Relaxometric studies shows that the
percentage change in T1 value of Gd-NBCB-TTDA-Legumain under the
different incubation time, increases 20 % in the presence of
3T3-Legumain cell lysate. The cytotoxicity results displayed that the cell
viability was more than 85% after the incubation of cells for 24 h under
high concentration of Gd-NBCB-TTDA-Legumain. The contrast agent
would be specifically recognized by Legumain enzyme around the tumor tissue, which results in significant tumor contrast enhancement at a dose of 0.1 mmol Gd/kg for at least 60 min in mice bearing CT-26 murine colon carcinoma xenografts for MR images. Therefore, the
Gd-NBCB-TTDA-Legumain can be potentially used as a contrast agent
for cancer molecular imaging.

並列關鍵字

Magnetic resonance imaging ； relaxivity

參考文獻

14. Ou, M. H.; Tu, C. H.; Tsai, S. C.; Lee, W. T.; Liu, G. C.; Wang, Y. M.,

10. Ou, M. H.; Chen, Y. M.; Chang, Y. H.; Lu, W. K.; Liuc, G. C.; Wang, Y.

22. Chang, Y. T.; Cheng, C. M.; Su, Y. Z.; Lee, W. T.; Hsu, J. S.; Liu, G. C.;

1. The Chemistry of Contrast Agents in Medical Magnetic Resonance

Imaging; Merbach, A. E., Toth, E., Eds.; John Wiley & Sons: Chichester,